Bifidobacterium spp.

Probiotics show potential in managing IBS symptoms, but evidence is mixed due to conflicting study results and small participant numbers. Specific strains like Lactobacillus acidophilus NCFM and Saccharomyces boulardii have shown promise in reducing symptoms such as abdominal pain and diarrhea. However, the effectiveness varies by individual, and more research is needed to determine the most beneficial strains for IBS.

Symbiotic supplements reduced BMI, waist circumference, and FBG levels, while increasing HDL levels. HbA1c levels increased in the placebo group. Probiotics and prebiotics show potential in improving metabolic and inflammatory biomarkers related to T2DM.

A study in *Nutrients* shows elderberry juice improves fat oxidation, glucose levels, and gut microbiota in overweight adults after one week, suggesting its potential in obesity management. Despite positive outcomes, longer studies are needed to confirm benefits and safety.

Gut microbiota composition differs in PCOS patients vs. healthy controls, with no significant alpha-diversity difference. PCOS subtypes show regional and testosterone-based variations in microbiota, with potential microbial biomarkers identified.

Aptamil KID C-SynB, containing Synbio+ (probiotics Bifidobacterium breve M-16V and prebiotics GOS/lcFOS), aims to restore gut dysbiosis in C-section-born children, supporting digestion, immune function, and overall health. Available in Malaysia since June, it is priced at RM68 for a 600g pack. Studies show it restores gut flora and supports immune development, reducing risks like asthma and obesity.